Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 495 results for "lymphocyte count"

Direct effect of dasatinib on signal transduction pathways ass...

Abstract It has been shown that an increase in cytotoxic lymphocyte counts in the peripheral blood occurs rapidly after taking dasatinib, but the underlying mechanism is not yet elucidated. To investigate the influence of dasatinib on signal ... Cancer Medicine, 2 weeks ago

Validation Study Of The Vi-CELL XR For Automated Cell Counting Of Dendritic Cells

By Iveta Bottova, PhD Dendritic cells (DC) population is a key functional constituent of cell based immunotherapy drugs. The correct cell count and adequate viability of DC are one of the quality control criteria for the final product release.
 Pharmaceutical Online1 week ago

AbbVie's New Oral Therapy VENCLEXTA Now Available For Canadians With A Difficult-To-Treat Blood Cancer

- Nearly 2,200 cases of chronic lymphocytic leukemia (CLL) are diagnosed every year in Canada . (i) - Up to 50% of previously treated CLL patients have a genetic mutation, known as 17p deletion, which results in a faster moving disease and a life ...
 Canada NewsWire2 weeks ago

Don't Let Dengue and Chikungunya Scare You. Be Prepared with This Comprehensive Guide

It has been a wet August for the countrywith heavy downpours and rain-like conditions persisting for days on end. Puddles of stagnant rainwater, left in the wake, have turned several cities in India into breeding grounds formosquitoes. As a result, ...
 Yahoo! India1 month ago

5 Years of Childhood Cancer Awareness And Counting

September is Childhood Cancer Awareness month and our color is gold. We gild our profile pictures and status updates with it in solidarity, driven to highlight the tiny warriors in our lives--the survivors, those still fighting and the dear ones ...
 Huffington Post1 month ago

Peripheral monocyte count: an independent diagnostic and prognostic biomarker for prostate cancer - a large Chinese cohort study

ORIGINAL ARTICLE Ahead of print publication Yan-Qing Wang 1 , Yin-Jie Zhu 1 , Jia-Hua Pan 1 , Fan Xu 1 , Xiao-Guang Shao 1 , Jian-Jun Sha 1 , Qiang Liu 2 , Yi-Ran Huang 1 , Bai-Jun Dong 1 , Wei Xue 1 1 Department of Urology, Renji Hospital, ...
 Asian Journal of Andrology1 month ago
Presentation Master

Pfizer Receives Positive CHMP Opinion For IBRANCE® (palbociclib) In Combination With Endocrine Therapy …

Monitor complete blood count prior to starting IBRANCE, at the beginning of each cycle, on Day 14 of first 2 cycles, and as clinically indicated. Dose interruption, dose reduction, or delay in starting treatment cycles is recommended for patients ...
 Yahoo! Finance1 month ago EMA Panel on Venetoclax and Other Products  General Medicine eJournal1 week ago Pending EC decision: Venclyxto, venetoclax, Opinion date: 13-Oct-2016  European Medicines Agency1 week ago First Positive Phase 3 Results in Adjuvant Setting for Renal Cell Carcinoma Show SUTENT® (sunitinib) Extended Disease Free Survival After Surgical Removal  Digital Journal2 weeks ago

AbbVie Announces Submission of a Supplemental New Drug Application for Ibrutinib (IMBRUVICA(R)) for Treatment of Marginal Zone Lymphoma

"We continue to explore the use of ibrutinib in non-Hodgkin's lymphoma, including marginal zone lymphoma and its three sub-types, given its unique mechanism of action and ability to target the B-cell receptor pathway," said Darrin Beaupre, M.D., ...
 Healthcare Sales & Marketing Network4 weeks ago Ibrutinib (IMBRUVICA®) Supplemental New Drug Application Submitted to the U.S. Food and Drug Administration (FDA) for Marginal Zone Lymphoma (MZL)  PR Newswire4 weeks ago Janssen Pharmaceutical Companies Release: Ibrutinib (IMBRUVICA) Supplemental New Drug Application Submitted To The FDA For Marginal Zone Lymphoma (MZL)  BioSpace4 weeks ago 9/26/16 - AbbVie Announces Submission of a Supplemental New Drug Application for Ibrutinib (IMBRUVICA®) for Treatment of Marginal Zone Lymphoma  Pharmacy Choice4 weeks ago

IL-12/IL-23p40 Is Highly Expressed in Secondary Lymphoid Organs and the CNS during All Stages of EAE, but Its Deletion Does Not Affect Disease Perpetuation

Abstract Background Interleukin (IL)-12 and IL-23 are heterodimers that share the p40 subunit, and both cytokines are critical in the differentiation of T helper (Th)1 and Th17 cells, respectively. Th1 and Th17 effector cells have been ...
 Plosone.org1 hour ago

Detailed examination of Global Relapsed Chronic Lymphocytic Leukemia (CLL) Clinical Trials Review, H2, 2016

GlobalData's clinical trial report, Relapsed Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H2, 2016" provides an overview of Relapsed Chronic Lymphocytic Leukemia (CLL) clinical trials scenario. This report provides top line data ...
 MyNewsDesk1 day ago Relapsed Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H2, 2016 - Market Size, Forecast and Recommendations  International Business Times22 hours ago Refractory Chronic Lymphocytic Leukemia (CLL) Market Global Clinical Trials Review,… week ago Strategic Analysis on Global Chronic Lymphocytic Leukemia (CLL) Market 2016  MyNewsDesk1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less